Literature DB >> 23602907

Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis.

Sylvette Ayala-Peña1.   

Abstract

Huntington's disease (HD) is a neurodegenerative disorder with an autosomal dominant expression pattern and typically a late-onset appearance. HD is a movement disorder with a heterogeneous phenotype characterized by involuntary dance-like gait, bioenergetic deficits, motor impairment, and cognitive and psychiatric deficits. Compelling evidence suggests that increased oxidative stress and mitochondrial dysfunction may underlie HD pathogenesis. However, the exact mechanisms underlying mutant huntingtin-induced neurological toxicity remain unclear. The objective of this paper is to review recent literature regarding the role of oxidative DNA damage in mitochondrial dysfunction and HD pathogenesis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3-NPA; 3-nitropropionic acid; 7,8-dihydro-8-oxoguanine-DNA glycosylase; 8-OHdG; 8-hydroxydeoxyguanosine; AP; ARE; ATM; ATR; BER; DNA repair; FEN1; HD; Huntington’s disease; MMR; Mitochondrial DNA; Mitochondrial bioenergetics; Mitochondrial dysfunction; NF-E2-related factor 2; Nrf2; OGG1; Oxidative stress; PGC-1α; POL β; PPARγ; ROS; Rad3-related kinase; Sirt; antioxidant response element; apurinic/apyrimidinic; ataxia telangiectasia mutated kinase; base excision repair; flap endonuclease 1; mismatch repair; peroxisome proliferator-activated receptor-γ; peroxisome proliferator-activated receptor-γ coactivator-1 α; polymerase beta; reactive oxygen species; sirtuins

Mesh:

Substances:

Year:  2013        PMID: 23602907      PMCID: PMC3722255          DOI: 10.1016/j.freeradbiomed.2013.04.017

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  150 in total

1.  trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease.

Authors:  Jinrong Fu; Jing Jin; Robert H Cichewicz; Serena A Hageman; Trevor K Ellis; Lan Xiang; Qi Peng; Mali Jiang; Nicolas Arbez; Katelyn Hotaling; Christopher A Ross; Wenzhen Duan
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

2.  Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease.

Authors:  Almas Siddiqui; Sulay Rivera-Sánchez; María del R Castro; Karina Acevedo-Torres; Anand Rane; Carlos A Torres-Ramos; David G Nicholls; Julie K Andersen; Sylvette Ayala-Torres
Journal:  Free Radic Biol Med       Date:  2012-06-16       Impact factor: 7.376

3.  Early alterations of brain cellular energy homeostasis in Huntington disease models.

Authors:  Fanny Mochel; Brandon Durant; Xingli Meng; James O'Callaghan; Hua Yu; Emmanuel Brouillet; Vanessa C Wheeler; Sandrine Humbert; Raphael Schiffmann; Alexandra Durr
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

4.  PGC-1α rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function.

Authors:  Taiji Tsunemi; Travis D Ashe; Bradley E Morrison; Kathryn R Soriano; Jonathan Au; Ruben A Vázquez Roque; Eduardo R Lazarowski; Vincent A Damian; Eliezer Masliah; Albert R La Spada
Journal:  Sci Transl Med       Date:  2012-07-11       Impact factor: 17.956

5.  Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.

Authors:  Ulziibat P Shirendeb; Marcus J Calkins; Maria Manczak; Vishwanath Anekonda; Brett Dufour; Jodi L McBride; Peizhong Mao; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2011-10-13       Impact factor: 6.150

6.  Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.

Authors:  Mali Jiang; Jiawei Wang; Jinrong Fu; Lin Du; Hyunkyung Jeong; Tim West; Lan Xiang; Qi Peng; Zhipeng Hou; Huan Cai; Tamara Seredenina; Nicolas Arbez; Shanshan Zhu; Katherine Sommers; Jennifer Qian; Jiangyang Zhang; Susumu Mori; X William Yang; Kellie L K Tamashiro; Susan Aja; Timothy H Moran; Ruth Luthi-Carter; Bronwen Martin; Stuart Maudsley; Mark P Mattson; Robert H Cichewicz; Christopher A Ross; David M Holtzman; Dimitri Krainc; Wenzhen Duan
Journal:  Nat Med       Date:  2011-12-18       Impact factor: 53.440

7.  Dithiol-based compounds maintain expression of antioxidant protein peroxiredoxin 1 that counteracts toxicity of mutant huntingtin.

Authors:  Andrea Pitts; Kyle Dailey; Jordan T Newington; Andrew Chien; Robert Arseneault; Tyler Cann; Leslie M Thompson; Robert C Cumming
Journal:  J Biol Chem       Date:  2012-05-10       Impact factor: 5.157

8.  8OHdG as a marker for Huntington disease progression.

Authors:  Jeffrey D Long; Wayne R Matson; Andrew R Juhl; Blair R Leavitt; Jane S Paulsen
Journal:  Neurobiol Dis       Date:  2012-03-05       Impact factor: 5.996

9.  Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway.

Authors:  Hyunkyung Jeong; Dena E Cohen; Libin Cui; Andrea Supinski; Jeffrey N Savas; Joseph R Mazzulli; John R Yates; Laura Bordone; Leonard Guarente; Dimitri Krainc
Journal:  Nat Med       Date:  2011-12-18       Impact factor: 53.440

10.  Neil1 is a genetic modifier of somatic and germline CAG trinucleotide repeat instability in R6/1 mice.

Authors:  Linda Møllersen; Alexander D Rowe; Jennifer L Illuzzi; Gunn A Hildrestrand; Katharina J Gerhold; Linda Tveterås; Anja Bjølgerud; David M Wilson; Magnar Bjørås; Arne Klungland
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

View more
  50 in total

1.  Transcriptional control of amino acid homeostasis is disrupted in Huntington's disease.

Authors:  Juan I Sbodio; Solomon H Snyder; Bindu D Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-19       Impact factor: 11.205

2.  Mitochondrial succinate dehydrogenase is involved in stimulus-secretion coupling and endogenous ROS formation in murine beta cells.

Authors:  Armin Edalat; Philipp Schulte-Mecklenbeck; Cita Bauer; Sabrina Undank; Peter Krippeit-Drews; Gisela Drews; Martina Düfer
Journal:  Diabetologia       Date:  2015-04-15       Impact factor: 10.122

3.  Golgi stress response reprograms cysteine metabolism to confer cytoprotection in Huntington's disease.

Authors:  Juan I Sbodio; Solomon H Snyder; Bindu D Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-09       Impact factor: 11.205

Review 4.  The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease.

Authors:  Aris A Polyzos; Cynthia T McMurray
Journal:  Mech Ageing Dev       Date:  2016-09-12       Impact factor: 5.432

Review 5.  The role of DNA base excision repair in brain homeostasis and disease.

Authors:  Mansour Akbari; Marya Morevati; Deborah Croteau; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2015-05-01

Review 6.  Exercise as Gene Therapy: BDNF and DNA Damage Repair.

Authors:  Robin H Schmidt; John M Nickerson; Jeffrey H Boatright
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2016 Jul-Aug

7.  Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.

Authors:  Huanhuan Luo; Liying Cao; Xuan Liang; Ana Du; Ting Peng; He Li
Journal:  Mol Neurobiol       Date:  2018-02-12       Impact factor: 5.590

Review 8.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

Review 9.  The Emerging Roles of Ferroptosis in Huntington's Disease.

Authors:  Yajing Mi; Xingchun Gao; Hao Xu; Yuanyuan Cui; Yuelin Zhang; Xingchun Gou
Journal:  Neuromolecular Med       Date:  2019-01-02       Impact factor: 3.843

Review 10.  Prospects for neuroprotective therapies in prodromal Huntington's disease.

Authors:  Abhishek Chandra; Ashu Johri; M Flint Beal
Journal:  Mov Disord       Date:  2014-02-26       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.